[1] |
Peng Jiangli, Chen Jie, Chen Yonggang, Wang Lu, Li Na, Luo Ji, Han Yi, Yu Mingli, Zhu Jiangchun.
SLC22A12 gene polymorphism study on susceptibility to hyperuricemia induced by pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 151-158.
|
[2] |
ZHOU Ting-ting, ZHENG Xiao-man, OUYANG Jing, LU Yan-qiu, CHEN Yao-kai.
Research progress on genes and mechanism of Mycobacterium tuberculosis resistance to pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 102-105.
|
[3] |
HU Yan-jie, GONG Shi-wei, REN Yi.
Establishment and evaluation of rapid detection of pyrazinamide resistance of Mycobacterium tuberculosis by probe enzyme digestion using Surveyor
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 813-816.
|
[4] |
WU Bi-tong, CAI Xing-shan, KUANG Hao-bin, LIU Zhi-hui, MENG Fan-rong, WANG Nan, GAO Jun-wen, TAN Shou-yong.
Correlation between pyrazinamidase activity and the short-term clinical efficacy of multidrug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1308-1313.
|
[5] |
ZHAO Yong, LIN Shu-fang, LIN Jian, DAI Zhi-song, WEI Shu-zhen.
Analysis of pyrazinamide resistance and pncA mutation in 125 multidrug-resistant Mycobacterium tuberculosis isolates
[J]. Chinese Journal of Antituberculosis, 2021, 43(10): 1079-1083.
|
[6] |
Bi-tong WU,Hao-bin KUANG,Zhi-hui LIU,Xing-shan CAI,Hong-juan QIN,Fan-rong MENG,Li-lan WU,Zhao-yuan LIN,De-hu PENG,Shou-yong TAN.
A comparative study of the efficacy of standard multidrug-resistant tuberculosis chemotherapy regimen for MDR-TB patients with pyrazinamide resistance or not
[J]. Chinese Journal of Antituberculosis, 2019, 41(4): 447-451.
|
[7] |
Shao-chen GUO,Hui ZHU,Chao GUO,Bin WANG,Zhong-quan LIU,Jian XU,Lei FU,Xiao-you CHEN,Yu LU.
Analysis of plasma concentrations of first-line anti-tuberculosis drugs in 909 tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2018, 40(7): 744-749.
|
[8] |
Da-mian ZHU,Dai-yu HU,Jie LIU,Yu PANG,Ming LUO,Jing SHEN,Lin. CHEN.
Analysis of mutation in pyrazinamide-resistance gene among the multidrug-resistant Mycobacterium tuberculosis strains isolated from Chongqing municipality
[J]. Chinese Journal of Antituberculosis, 2018, 40(2): 177-182.
|
[9] |
LIN Shu-fang,WEI Shu-zhen,ZHAO Yong,LIN Jian,LIN Yong-ming..
Phenotypic pyrazinamide resistance and genotypic characteristics among multidrug-resistant Mycobacterium tuberculosis isolates in Fujian Province
[J]. Chinese Journal of Antituberculosis, 2018, 40(12): 1330-1334.
|
[10] |
ZHU Hui, WANG Bin, FU Lei, LIU Cheng-cheng, LU Yu.
Pharmacokinetics comparison of pyrazinamide once and three times daily in mice and its influence on isoniazid-rifampicin
[J]. Chinese Journal of Antituberculosis, 2013, 35(12): 983-987.
|
[11] |
WANG Dong-min, LIN Jian-xiong, PENG Dong-dong, LI Jin-zhan, LI Geng-cong, LI Hong-bing, CHEN Rui-ming.
The value of particle colorimetric technique in rapid detection of Mycobacterium tuberculosis resistance to pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2011, 33(9): 596-599.
|
[12] |
Li Huiwen,Liang Guifang,Zhao Weijie,et al..
Study on the activity of the Fixed-dose combination in antituberculous
[J]. Chinese Journal of Antituberculosis, 2007, 29(5): 423-428.
|
[13] |
Zha Yuefang,Zeng Wen,Hu Jianjun,et al..
Study on the hepatoxicity induced by antitubercular medicines in rat models
[J]. Chinese Journal of Antituberculosis, 2006, 28(3): 174-177.
|